MYOXYDOL
MERINAL
Identification
- Active ingredient (INN)
- IBUPROFENE / METHOCARBAMOL
- Internal code
- 21 E 073
- Country of Origin
- Algeria
- Pharmaceutical form
- Bilayer Film-coated Tablet
- Prescription List
- Regulated (List II)
- Packaging
- boite de 30
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Description
tablet ibuprofen: 400 mg Respect an interval of at least 6 hours between 2 doses 400 mg 1-3 times a day Respect an interval of at least 6 hours between 2 doses 400 mg 1-3 times a day 400 mg 1 time per day Respect an interval of at least 6 hours between 2 doses 400-800 mg 3 times a day The information provided on drug interactions results from the synthesis of the sources consulted by the Vidal scientific team.
They do not systematically reflect the information contained in the SPCs.
They are intended for practical purposes for health professionals.
The absence of an AMI in the Vidal database must never be interpreted as proof of safety. name: IBUPROFENE B. cip13:3400930200131 conservation: Cip: 3400930200131 Storage conditions: Before opening: for 36 months status: Marketed.
Mechanism of Action
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID), belonging to the propionic group, derived from arylcarboxylic acid.
It has analgesic, antipyretic, anti-inflammatory and short-term inhibitory properties of platelet functions.
All of these properties are linked to an inhibition of prostaglandin synthesis.
Adverse Effects
syndrome INFECTIOLOGY OF BACTERIAL ORIGIN INFECTIOLOGY OF VIRAL ORIGIN NUTRITION, METABOLISM OPHTHALMOLOGY ENT, STOMATOLOGY PSYCHIATRY CARDIOVASCULAR SYSTEM DIGESTIVE SYSTEM NERVOUS SYSTEM RESPIRATORY SYSTEM UROLOGY, NEPHROLOGY.